Author

Pieter‐Jan de Kam

Observed names: P DeKam, P J De Kam, P J de Kam, P. De Kam, P. De-Kam, P. J. De Kam, P. J. de Kam, P. de Kam, P.-J. de Kam, P.J. De Kam, P.J. de Kam, Pieter-Jan De Kam, Pieter-Jan de Kam, Pieter‐Jan De Kam, Pieter‐Jan De Kam

Institution: Allergy Therapeutics (United Kingdom)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), University Medical Center Groningen, University of Groningen, Sahlgrenska University Hospital, Amsterdam UMC Location University of Amsterdam, University Hospital Regensburg, St. Antonius Ziekenhuis, MSD (Singapore), HAL Allergy (Netherlands), Allergy Therapeutics (United Kingdom), MSD (Netherlands), Organon (Netherlands)

ORCID: 0000-0003-0859-4862

Observed ORCID: 0000-0003-0859-4862

OpenAlex ID: A5060366723

Left ventricular beat-to-beat performance in atrial fibrillation: Contribution of frank-starling mechanism after short rather than long RR intervals

1995 · A.T. Marcel Gosselink, Paul K. Blanksma, et al. · Journal of the American College of Cardiology · 110

Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers

2008 · G Cammu, P.J. De Kam, et al. · British Journal of Anaesthesia · 97

Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients

2000 · H. G. D. Hendriks, J. van der Meer, et al. · Blood Coagulation & Fibrinolysis · 72

Plasma Levels of Protein S, Protein C, and Factor X: Effects of Sex, Hormonal State and Age

1995 · C M A Henkens, V J J Bom, et al. · Thrombosis and Haemostasis · 67

Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers

2018 · P.-J. de Kam, H. Nolte, et al. · British Journal of Anaesthesia · 65

PDF

Repeat dosing of rocuronium 1.2 mg kg−1 after reversal of neuromuscular block by sugammadex 4.0 mg kg−1 in anaesthetized healthy volunteers: a modelling-based pilot study

2010 · G Cammu, P.-J. de Kam, et al. · British Journal of Anaesthesia · 61

Effects of Aspirin on Angiotensin-Converting Enzyme Inhibition and Left Ventricular Dilation One Year After Acute Myocardial Infarction

1998 · Margreeth Oosterga, Rutger L Anthonio, et al. · The American Journal of Cardiology · 56

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma

2018 · Oliver Pfaar, Claus Bachert, et al. · Journal of Allergy and Clinical Immunology · 50

PDF

Effects of Sugammadex Doses up to 32 mg/kg Alone or in Combination with Rocuronium or Vecuronium on QTc Prolongation: A Thorough QTc Study

2010 · Pieter-Jan de Kam, Jacqueline van Kuijk, et al. · Clinical Drug Investigation · 50

Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects

2014 · Pieter-Jan De Kam, Peter Grobara, et al. · International Journal of Clinical Pharmacology and Therapeutics · 47

Long-term outcome of electrical cardioversion in patients with chronic atrial flutter.

1997 · H. J. Crijns, I. C. Van Gelder, et al. · Heart · 46

PDF

Left ventricular beat to beat performance in atrial fibrillation: dependence on contractility, preload, and afterload

1999 · H J Muntinga, A T M Gosselink, et al. · Heart · 43

PDF

Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report

2021 · Oliver Pfaar, Karl‐Christian Bergmann, et al. · Allergy · 42

PDF

Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study

2012 · Pieter-Jan de Kam, Jacqueline van Kuijk, et al. · International Journal of Clinical Pharmacology and Therapeutics · 34

Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis

2001 · J. R. Meinardi, S. Middeldorp, et al. · Blood Coagulation & Fibrinolysis · 30

Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy

2023 · P. J. de Kam, S. Zielen, et al. · Allergy · 29

PDF

Plasma Angiotensin-Converting Enzyme Activity and Left Ventricular Dilation After Myocardial Infarction

1997 · Margreeth Oosterga, Adriaan A. Voors, et al. · Circulation · 29

SCIT-treatment With a Chemically Modified, Aluminum Hydroxide Adsorbed Peanut Extract (HAL-MPE1) Was Generally Safe And Well Tolerated And Showed Immunological Changes In Peanut Allergic Patients

2017 · Carsten Bindslev-Jensen, Pieter-Jan de Kam, et al. · Journal of Allergy and Clinical Immunology · 28

No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters

2013 · Pieter-Jan de Kam, Rachid El Galta, et al. · International Journal of Clinical Pharmacology and Therapeutics · 28

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)

2020 · Matthew D. Heath, Mona O. Mohsen, et al. · Frontiers in Immunology · 26

PDF

Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing

2019 · S. Zielen, P. Kuna, et al. · World Allergy Organization Journal · 22

Effect of Sugammadex on QT/QTc Interval Prolongation when Combined with QTc-Prolonging Sevoflurane or Propofol Anaesthesia

2013 · Pieter-Jan de Kam, Peter Grobara, et al. · Clinical Drug Investigation · 22

Discovery and Clinical Evaluation of MK‐8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release

2016 · Clayton D. Knox, Pieter‐Jan de Kam, et al. · Journal of the American Heart Association · 18

Development of In Vitro – In Vivo Correlation for Extended‐Release Niacin After Administration of Hypromellose‐Based Matrix Formulations to Healthy Volunteers

2014 · Filippos Kesisoglou, Stefaan Rossenu, et al. · Journal of Pharmaceutical Sciences · 18

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

2014 · Pieter-Jan De Kam, Annelieke C. Kruithof, et al. · International Journal of Clinical Pharmacology and Therapeutics · 18

Works count: 81

Citation count: 1,260

H-index: 22

I10-index: 32